Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF.
Trum M, Riechel J, Schollmeier E, Lebek S, Hegner P, Reuthner K, Heers S, Keller K, Wester M, Klatt S, Hamdani N, Provaznik Z, Schmid C, Maier L, Arzt M, Wagner S.
Trum M, et al. Among authors: provaznik z.
Cardiovasc Res. 2024 Jul 31;120(9):999-1010. doi: 10.1093/cvr/cvae095.
Cardiovasc Res. 2024.
PMID: 38728438
Free PMC article.